跳至主要内容
临床试验/TCTR20220930003
TCTR20220930003已完成2 期

Efficacy of Preoperative Intravenous Tranexamic Acid Before Caesarean Section in Placenta Previa : a randomized double blind control trial

none0 个研究点目标入组 60 人开始时间: 2022年9月30日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
Female

入选标准

  • 1. All pregnant woman with placenta previa diagnosed by transabdominal or transvaginal ultrasound(if not clearly by TAS) confirmed at GA 28 week by obstetricians
  • 3.undergoing caesarean delivery for placenta previa include elective c/s at term (37+ week) or emergency c/s due to placenta previa
  • 4.Repeat ultrasound confirm before caesarean section
  • 5.Age > 18 year and already informed consent

排除标准

  • 1. Allergic patient to transamine
  • 2. Undergo caesarean section due to placenta previa before GA 28 week
  • 3. follow up by ultrasound during antenatal care and diagnosis was changed
  • 4. Patient with showed any sign of adherent placenta on ultrasound
  • 5. Patient with active cardiac, hepatic, renal disease
  • 6. patient with risk factor for VTE such as prior VTE, thrombophilia disease**, hematologic cancer, immobilize patient, first degree relative history of VTE, morbid obesity BMI>40
  • 7.Underlying disease of Coagulopathy, thrombocytopenia or on anticoagulant
  • 8. patient cannot make decision

研究者

发起方
none

相似试验

Efficacy of Preoperative Intravenous Tranexamic Acid... | 临床试验